The normal variabilities of the menstrual cycle

Fertility and Sterility

Volumn 91, Issue 2, 2009, Pages 522-527

  Cole, Laurence A ^a   Ladner, Donald G ^a   Byrn, Francis W ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

hCG; implantation; LH; LH Peak; luteal phase; menstrual cycle

Indexed keywords

CHORIONIC GONADOTROPIN; LUTEINIZING HORMONE;

ADULT; ARTICLE; CLINICAL PRACTICE; EPIDEMIOLOGICAL DATA; FEMALE; GESTATIONAL AGE; HORMONE ACTION; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MENSTRUAL CYCLE; NIDATION; NORMAL HUMAN; OVULATION; PREGNANCY; PRIORITY JOURNAL; PROSPECTIVE STUDY; UNITED STATES; URINALYSIS;

ADOLESCENT; ADULT; CHORIONIC GONADOTROPIN; EMBRYO IMPLANTATION; FEMALE; HUMANS; LUTEINIZING HORMONE; MENSTRUAL CYCLE; OVULATION; PREGNANCY; PROSPECTIVE STUDIES; REFERENCE VALUES; TIME FACTORS; YOUNG ADULT;

EID: 59249092799     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.11.073     Document Type: Article

References (27)

1. Corner G.W. Our knowledge of the menstrual cycle, 1910-1950. Lancet 1 (1951) 919-923
2. Pratt J.P. The normal menstrual cycle. Southern Med J 44 (1951) 812-817
3. Persky H. Excetion of luteinizing hormone (LH) by normal human subjects. J Albert Einstein Med Ctr 12 (1964) 29-33
4. Midgley Jr. A.R., and Jaffe R.B. Human luteinizing hormone in serum during the menstrual cycle: determination by radioimmunoassay. J Clin Endocrinol Metab 26 (1966) 1375-1381
5. Ross G.T., Odell W.D., and Rayford P.L. Luteinizing hormone activity in plasma during the menstrual cycle. Science 155 (1967) 1679-1680
6. Neill J.D., Johansson E.D., Datta J.K., and Knobil E. Relationship between the plasma levels of luteinizing hormone and progesterone during the normal menstrual cycle. J Clin Endocrinol Metab 27 (1967) 1167-1173
7. Treloar A.E., Boynton R.E., Behn B.G., and Brown B.W. Variation of the human menstrual cycle through reproductive life. lntl J Fert 12 (1967) 77-126
8. Harlow S.D., Lin X., and Ho M.J. Analysis of menstrual diary data across the reproductive life span applicability of the bipartite model approach and the importance of within-women variance. J Clin Epidemiol 53 (2000) 722-733
9. Harlow S.D., and Ephross S.A. Epidemiology of menstruation and its relevance to women's health. Epidemiol Rev 17 (1995) 265-286
10. Lenton E.A., Landgren B.M., and Sexton L. Normal variation in the length of the luteal phase of the menstrual cycle. Br J Obstet Gynecol 91 (1984) 685-689
11. Lenton E.A., Landgren B.M., Sexton L., and Harper R. Normal variation in the length of the follicular phase of the menstrual cycle. Br J Obstet Gynecol 91 (1984) 681-684
12. Lenton E.A., Lawrence G.F., Coleman R.A., and Cooke I.D. Individual variation in gonadotrophin and steroid concentrations and in the lengths of the follicular and luteal phases in women with regular menstrual cycles. Clin Reprod Fertil 2 (1983) 143-150
13. Wilcox A.J., Baird D.D., Dunson D., McChesney R., and Weinberg C.R. Natural limits of pregnancy testing in relation to the expected menstrual period. J Am Med Assoc 286 (2001) 1759-1761
14. Wilcox A.J., Baird D.D., and Weinberg C.R. Time of implantation of the conceptus and loss of pregnancy. New Engl J Med 340 (1999) 1796-1799
15. Wilcox A.J., Weinberg C.R., and Baird D.D. Timing of sexual intercourse in relation to ovulation. Effects of the probability of conception, survival of the pregnancy, and sex of the baby. New Engl J Med 333 (1995) 1517-1521
16. Elliott M.M., Kardana A., Lustbader J.W., and Cole L.A. Carbohydrate and peptide structure of the α- and β-subunits of human chorionic gonadotropin from normal and aberrant pregnancy and choriocarcinoma. Endocrine 7 (1997) 15-32
17. Cole L.A., Dai D., Leslie K.K., Butler S.A., and Kohorn E.I. Gestational trophoblastic diseases. 1. Pathophysiology of hyperglycosylated hCG-regulated neoplasia. Gynecol Oncol 102 (2006) 144-149
18. Sasaki Y., Ladner D., and Cole L.A. Hyperglycosylated hCG and the source of pregnancy failures. Fertil Steril (6 August 2007) [E-pub ahead of print]
19. Kovalevskaya G., Birken S., Kakuma T., Ozaki N., Sauer M., Lindheim S., et al. Differential expression of human chorionic gonadotropin (hCG) glycosylation isoforms in failing and continuing pregnancies: preliminary characterization of the hyperglycosylated hCG epitope. J Endocrinol 172 (2002) 497-506
20. Cole L.A., Shahabi S., Oz U.A., Bahado-Singh R.O., and Mahoney M.J. Hyperglycosylated hCG (invasive trophoblast antigen) immunoassay: a new basis for gestational down syndrome screening. Clin Chem 45 (1999) 2109-2119
21. Cho S.I., Goldman M.B., Ryan L.M., Chen C., Damokosh A.I., Christiani D.C., et al. Reliability of serial urine hCG as a biomarker to detect early pregnancy loss. Hum Reprod 17 (2002) 1060-1066
22. O'Connor J.F., Birken S., Lustbader T.W., Krichevsky A., Chen Y., and Canfield R.E. Recent advances in the chemistry and immunochemistry of human chorionic gonadotropin: impact on clinical measurements. Endocrine Rev 15 (1994) 650-682
23. Kovalevskaya G., Kakuma T., Schlatterer J., and O'Connor J.F. Hyperglycosylated hCG expression in pregnancy: cellular origin and clinical application. Mol Cell Endocrinol 260 (2007) 237-243
24. Baird D.D., Weinberg C.R., Wilcox A.J., McConnaughey D.R., and Musey P.I. Using the ratio of urinary oestrogen and progesterone metabolites to estimate day of ovulation. Stat Med 10 (1991) 255-266
25. O'Connor K.A., Brindle E., Miller R.C., Shofer J.B., Ferrel T.J., Klein N.A., et al. Ovulation detection methods for urinary hormones: precision, daily and intermittent sampling and a combined hierachial method. Hum Reprod 21 (2006) 1442-1452
26. Cole L.A., Khanlian S.A., Sutton J.M., Davies S., and Stephens N. Hyperglycosylated hCG (invasive trophoblast antigen, ITA) a key antigen for early pregnancy detection. Clin Biochem 36 (2003) 647-655
27. Sutton-Riley J.M., Khanlian S.A., Byrn F.W., and Cole L.A. A single serum test for measuring early pregnancy outcome with high predictive value. Clin Biochem 39 (2006) 682-687